@inproceedings{inproceedings, title  = {{161 52-Week Laboratory Safety Findings From an Open-Label Extension Study of Dupilumab in Adolescent Patients With Atopic Dermatitis (LIBERTY AD PED-OLE)}},

 publisher = {{BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health}},

 url = {{https://doi.org/10.1136/archdischild-2021-europaediatrics.161 }},

 year = {{2021}},

 month = {{10}},

 author = {{Cork MJ and Lockshin B and Blauvelt A and Chen Z and Khokhar FA and Bansal A and Prescilla R}},

 doi = {{10.1136/archdischild-2021-europaediatrics.161}},

 journal = {{Abstracts}},

 pages = {{A68.2-A69}},

 note = {{Accessed on 2025/11/05}}}